![Rikard Rodén](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Cargos activos de Rikard Rodén
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
MEDIROX AB | Director Ejecutivo | 01/06/2017 | - |
Nordic Biomarker AB
![]() Nordic Biomarker AB Pharmaceuticals: MajorHealth Technology Nordic Biomarker AB is a Swedish manufacturer of routine and specialty reagents for coagulation analysis. Nordic Biomarker is based in Umeå, SE. The Swedish company offers CE-marked kits and OEM products, available in vials or bulk, intended for calibration of MRX D-dimer assays run on coagulation analyzers, in ng/mL DDU. The company's FDP reagent is optimized for assay with coagulation analyzers at 500-700 nm, where 550 nm and 575 nm is most commonly used. The company was founded in 2007 by Gunnar Pohl and Göran Aronsson, and the CEO is Rikard Rodén. | Director Ejecutivo | - | - |
Historial de carrera de Rikard Rodén
Estadísticas
Internacional
Suecia | 3 |
Operativa
Chief Executive Officer | 2 |
Sectorial
Health Technology | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 2 |
---|---|
MediRox AB
![]() MediRox AB Pharmaceuticals: MajorHealth Technology MediRox AB engages in developing, manufacturing and marketing of control plasmas and diagnostic reagents for coagulation analytes. Its products include PT, APTT, AT, TT, Fib Clauss and D-Dimer within the field of haemostasis. The company was founded in 1998 and is headquartered in Nykoping, Sweden. | Health Technology |
Nordic Biomarker AB
![]() Nordic Biomarker AB Pharmaceuticals: MajorHealth Technology Nordic Biomarker AB is a Swedish manufacturer of routine and specialty reagents for coagulation analysis. Nordic Biomarker is based in Umeå, SE. The Swedish company offers CE-marked kits and OEM products, available in vials or bulk, intended for calibration of MRX D-dimer assays run on coagulation analyzers, in ng/mL DDU. The company's FDP reagent is optimized for assay with coagulation analyzers at 500-700 nm, where 550 nm and 575 nm is most commonly used. The company was founded in 2007 by Gunnar Pohl and Göran Aronsson, and the CEO is Rikard Rodén. | Health Technology |
- Bolsa de valores
- Insiders
- Rikard Rodén
- Experiencia